On Friday, Shares of EnteroMedics Inc (NASDAQ:ETRM), lost -6.57% to $0.270.
EnteroMedics Inc., declared that Mark B. Knudson, Ph.D., EnteroMedics Founder, Chairman, President and Chief Executive Officer notified the Company of his intention to retire effective December 31, 2015. Dr. Knudson will remain Chairman of the EnteroMedics Board of Directors. The Company also declared that Jon Tremmel, a Member of the Company’s Board of Directors, has been designated as Consultant to the CEO. Mr. Tremmel will lead a search committee to find a successor for the chief executive role in addition to provide planned advice to the Company regarding its commercialization and reimbursement activities during the transition.
EnteroMedics, founded by Dr. Knudson in 2003, is one of over 20 healthcare companies that he has started or assisted establish. Before EnteroMedics, Dr. Knudson held administration positions in Research and Development at Cardiac Pacemakers, Inc. (CPI-Guidant) and was a member of the faculty of the University of Washington School of Medicine in Seattle, Washington. He was the recipient of an Individual Post-doctoral Fellowship Award from the National Institutes of Health. Dr. Knudson received a Ph.D. degree (Physiology) from Washington State University and a B.S. degree in biology from Pacific Lutheran University. He holds numerous United States patents and serves or has served on boards of several companies and institutions, both public and private. Dr. Knudson was elected to membership in Sigma Xi, the scientific research society of North America in 1975 and is a Fellow of the American Heart Association.
“I have had the privilege of being involved in numerous companies from conception to generation and have found it particularly rewarding to see EnteroMedics’ vBloc Neurometabolic Therapy evolve to where it stands now, available to both patients and physicians who have been waiting over a decade for a new treatment option for obesity and its comorbidities,” said Mark B. Knudson, Ph.D., President and Chief Executive Officer. “I am extremely proud of the way we have overcome multiple challenges along the way and of the progress we’ve made thus far. I feel confident that the company is headed in the right direction. I will continue to lead the organization through the transition and look forward to maintaining my role as Chairman of the Board.”
EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
Shares of Scorpio Bulkers Inc (NYSE:SALT), declined -1.22% to $1.62, during its last trading session.
Scorpio Bulkers Inc., declared that Scorpio Services Holding Limited has purchased an aggregate of 552,481 common shares of the Company at an average price of $1.61 per share in the open market since the Company’s previous declaration on August 24, 2015. The Company presently has 336,107,741 common shares outstanding, of which SSH owns 19,222,421, or 5.7%.
Scorpio Bulkers Inc., together with its auxiliaries, engages in the marine transportation of dry bulk commodities. Its fleet transports a range of major and minor bulk commodities, counting ores, coal, grains, and fertilizers along worldwide shipping routes.
At the end of Friday’s trade, Shares of CYS Investments Inc (NYSE:CYS), lost -1.29% to $7.63.
CYS Investments declared that Kevin E. Grant, CFA, the Company’s CEO and President, would deliver a presentation at the Barclays Global Financial Services Conference at the New York Hilton Midtown Hotel in New York City on Thursday, September 17, 2015 at about 7:30 a.m. (ET).
CYS Investments, Inc., a specialty finance company, invests in residential mortgage pass-through securities in the United States. It also focuses on investing in residential mortgage-backed securities that are issued and the principal and interest of which are guaranteed by a federally chartered corporation (Agency RMBS); debt securities issued by the United States Department of Treasury or a government sponsored entity; and collateralized mortgage obligations issued by a government agency or government-sponsored entity that are collateralized by Agency RMBS.
Finally, Time Warner Cable Inc (NYSE:TWC), ended its last trade with -0.13% loss, and closed at $187.83.
Just in time for the most highly anticipated tennis event of the season – the 2015 US OPEN – Time Warner Cable Inc., declared professional tennis player Sloane Stephens will star in the company’s new STEM in Tennis campaign. STEM in Tennis, created as an extension of TWC’s STEM in Sports program, is part of the company’s signature Connect a Million Minds (CAMM) initiative. CAMM was designed to inspire the next generation of problem solvers by connecting young people to the wonders of science, technology, engineering, and math (STEM).
In partnership with the USTA Foundation, the national charitable organization of the U.S. Tennis Association (USTA), TWC created a national Public Service Declaration (PSA) featuring Stephens that highlights the importance of math and science in tennis. The PSA will start running in TWC service areas nationwide recently.
“We’re so thrilled that Sloane Stephens teamed up with Time Warner Cable to show young people how STEM applies to the game of tennis,” said Ellen East, Time Warner Cable’s EVP and Chief Communications Officer. “TWC is proud to expand on our signature program Connect a Million Minds to bring kids the tools and resources they need to understand how STEM impacts everything around them, counting the sports they love.”
Time Warner Cable Inc., together with its auxiliaries, provides video, high-speed data, and voice services in the United States. It operates in three segments: Residential Services, Business Services, and Other Operations.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
